Sandostatin LAR 30 mg prašak i otapalo za suspenziju za injekciju
Name | Sandostatin LAR 30 mg prašak i otapalo za suspenziju za injekciju |
---|---|
Marketing Authorisation Number | HR-H-983646054 |
Active Substance | oktreotidacetat |
Composition | jedna bočica sadrži 30 mg oktreotida (u obliku oktreotidacetata) |
Pharmaceutical Form | prašak i otapalo za suspenziju za injekciju |
Manufacturer | Novartis Pharma GmbH, Nürnberg, Njemačka
Novartis Farmacéutica S.A., Barcelona, Španjolska |
Marketing Authorisation Holder | Novartis Hrvatska d.o.o., Radnička cesta 37b, Zagreb, Hrvatska |
Marketing Authorisation Date | 13.03.2019 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/19-02/14 |
Registration Number | 381-12-01/70-19-02 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | H01CB02 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |